Access to device-aided therapies in advanced Parkinson’s disease: navigating clinician biases, patient preference, and prognostic uncertainty

Device-aided therapies (DAT), which include deep brain stimulation and pump-based continuous dopaminergic stimulation with either levodopa or apomorphine, are among the major advances in the clinical management of Parkinson’s disease (PD). Although DAT are being increasingly offered earlier in the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Auffret, Manon, Weiss, Daniel, Stocchi, Fabrizio, Vérin, Marc, Jost, Wolfgang H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Neurology and Preclinical Neurological Studies - Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645670/
https://www.ncbi.nlm.nih.gov/pubmed/37436446
http://dx.doi.org/10.1007/s00702-023-02668-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645670/
https://www.ncbi.nlm.nih.gov/pubmed/37436446
http://dx.doi.org/10.1007/s00702-023-02668-9

Ejemplares similares